Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
International Journal of Clinical Oncology|June 26, 2016
Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky massTadahiro Shoji, Eriko Takatori, Yoko Furutake, et al.
Oncology Reports|May 2, 2013
Investigation of the clinicopathological features of fallopian tube malignancyYoshihito Yokoyama, Masayuki Futagami, Toshio Fujimoto, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 19, 2011
Phase II clinical study of the combination chemotherapy regimen of irinotecan plus oral etoposide for the treatment of recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 101 Group Study)Tadahiro Shoji, Eriko Takatori, Hideo Omi, et al.
International Cancer Conference Journal|July 23, 2026
Clinical utility of diagnostic laparoscopy for ovarian metastasis from breast cancer in a BRCA1-mutated patient with hereditary breast and ovarian cancer syndrome: a case report and literature reviewSho Sato, Mitsumasa Osakabe, Shingo Hosomi, et al.
Cancer Chemotherapy and Pharmacology|June 29, 2017
A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)Tadahiro Shoji, Eriko Takatori, Hideo Omi, et al.
International Journal of Clinical Oncology|January 30, 2026
Safety and oncologic outcomes of total laparoscopic versus abdominal hysterectomy following diagnostic conization for adenocarcinoma in situ and stage IA1 cervical cancer: a multicenter retrospective studyYoshitaka Kaido, Masahiro Kagabu, Yohei Chiba, et al.
International Journal of Clinical Oncology|October 10, 2022
Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study)Tadahiro Shoji, Eriko Takatori, Takayuki Nagasawa, et al.
Cancers|November 27, 2024
Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study)Tadahiro Shoji, Eriko Takatori, Takayuki Nagasawa, et al.
Pageof 5